|
Dehinel
|
-
|
V/DCP/17/0010
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0010-01 |
|
2 |
Blisteris, 1 tablete |
[PDF]
[PDF]
|
| V/DCP/17/0010-02 |
|
4 |
Blisteris, 1 tablete |
[PDF]
[JPG]
|
| V/DCP/17/0010-03 |
|
10 |
Blisteris, 1 tablete |
-
|
| V/DCP/17/0010-04 |
|
30 |
Blisteris, 1 tablete |
[PDF]
[PDF]
|
| V/DCP/17/0010-05 |
|
50 |
Blisteris, 1 tablete |
-
|
| V/DCP/17/0010-06 |
|
100 |
Blisteris, 1 tablete |
-
|
|
|
Bimacox
|
2.5 mg/ml
|
V/DCP/24/0053
|
Bimeda Animal Health Limited, Īrija
|
QP51BC03
|
cattle; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0053-01 |
|
1 |
Polietilēna konteiners, 1 l |
-
|
| V/DCP/24/0053-02 |
|
1 |
Polietilēna konteiners, 2,5 l |
-
|
| V/DCP/24/0053-03 |
|
1 |
Polietilēna konteiners, 5 l |
-
|
|
|
Torphadine vet
|
10 mg/ml
|
V/DCP/16/0032
|
Le Vet Beheer B.V., Nīderlande
|
QN02AF01
|
horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0032-01 |
10 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/16/0032-02 |
10 mg/ml |
1 |
Stikla flakons, 20 ml |
-
|
|
|
Sordex
|
-
|
V/NRP/19/0004
|
V.M.D. n.v., Beļģija
|
QB05BA03
|
cattle; pigs; sheep; horses; dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for infusion
|
| International name (active substance): |
Glucose monohydrate, Sorbitol
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratoires Biove, Francija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 280619_LI (28-Jun-2019)
|
| Labelling text: |
[PDF] 280619_M (28-Jun-2019)
|
| Summary of product characteristics: |
[PDF] 280619_ZA (28-Jun-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/19/0004-01 |
|
1 |
Flakons, 500 ml |
-
|
|
|
Gallimune Se+St
|
-
|
V/DCP/08/1601
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QI01AB01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
water in oil emulsion for injection
|
| International name (active substance): |
Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated, Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health Italia S.p.A., Itālija
|
| Date of authorisation/renewal: |
04-Apr-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (23-Jan-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/08/1601-01 |
|
1 |
Flakons, 1000 deva |
-
|
| V/DCP/08/1601-02 |
|
10 |
Flakons, 1000 deva |
-
|
|
|
Vetofol
|
10 mg/ml
|
V/MRP/11/0013
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QN01AX10
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Propofol
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
|
| Date of authorisation/renewal: |
28-Dec-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] 130619LI (13-Jun-2019)
|
| Labelling text: |
[PDF] 040619M (04-Jun-2019)
|
| Summary of product characteristics: |
[PDF] 040619ZA (04-Jun-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/11/0013-01 |
10 mg/ml |
1 |
Stikla flakons, 20 ml |
-
|
| V/MRP/11/0013-02 |
10 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Inmunair 17.5
|
-
|
V/NRP/02/1442
|
Laboratorios Calier, S.A., Spānija
|
QL03A
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Inactivated cells of Propionibacterium acnes,Lipopolysaccharide of E.coli cells
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratories Calier S.A., Spānija
|
| Date of authorisation/renewal: |
20-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 130519LI (13-May-2019)
|
| Labelling text: |
[PDF] 130519M (13-May-2019)
|
| Summary of product characteristics: |
[PDF] 130519ZA (13-May-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1442-01 |
|
1 |
Polietilēna flakons, 50 ml |
-
|
| V/NRP/02/1442-02 |
|
1 |
Polietilēna flakons, 100 ml |
-
|
| V/NRP/02/1442-03 |
|
1 |
Polietilēna pudele, 250 ml |
-
|
| V/NRP/02/1442-04 |
|
1 |
Polietilēna pudele, 500 ml |
-
|
|
|
Mektix CHEWABLE 2,5 mg/25 mg
|
-
|
V/DCP/21/0050
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP54AB51
|
small dogs; puppies weighing at least 0.5 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0050-01 |
2,5/25 mg |
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/21/0050-02 |
2,5/25 mg |
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/21/0050-03 |
2,5/25 mg |
12 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Mektix CHEWABLE 12,5 mg/125 mg
|
-
|
V/DCP/21/0051
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP54AB51
|
dogs weighing at least 5 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0051-01 |
12,5/125 mg |
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/21/0051-02 |
12,5/125 mg |
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/21/0051-03 |
12,5/125 mg |
12 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Xylamidor
|
20 mg/ml
|
V/DCP/23/0025
|
VetViva Richter GmbH , Austrija
|
QN05CM92
|
cattle; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0025-01 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/23/0025-02 |
|
1 |
Stikla flakons, 25 ml |
[PDF]
[PDF]
|
| V/DCP/23/0025-03 |
|
1 |
Stikla flakons, 50 ml |
[PDF]
[PDF]
|
| V/DCP/23/0025-04 |
|
5 |
Stikla flakons, 10 ml |
-
|
|
|
Rispoval 2/BRSV + Pi3
|
-
|
V/DCP/20/0058
|
Zoetis Belgium S.A., Beļģija
|
QI02AD07
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Bovine Parainfluenza 3 virus (Pi3V), modified live strain RLB 103, Bovine Respiratory Syncytial Virus (BRSV), modified live strain 375
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0058-01 |
|
1 |
Stikla flakons, 5 deva |
-
|
| V/DCP/20/0058-02 |
|
1 |
Stikla flakons, 25 deva |
-
|
|
|
Clavusan 50 mg + 12,5 mg
|
-
|
V/DCP/23/0009
|
Alfasan Nederland BV, Nīderlande
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0009-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0009-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0009-03 |
|
5 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0009-04 |
|
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0009-05 |
|
25 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Clavusan 250 mg + 62,5 mg
|
-
|
V/DCP/23/0010
|
Alfasan Nederland BV, Nīderlande
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0010-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0010-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0010-03 |
|
5 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0010-04 |
|
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0010-05 |
|
25 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Clavusan 500 mg + 125 mg
|
-
|
V/DCP/23/0011
|
Alfasan Nederland BV, Nīderlande
|
QJ01CR02
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0011-01 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0011-02 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0011-03 |
|
5 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0011-04 |
|
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/23/0011-05 |
|
25 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Comforion Vet
|
100 mg/ml
|
V/SRP/23/0064
|
Orion Corporation Orion Pharma, Somija
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/SRP/23/0064-01 |
100 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/SRP/23/0064-02 |
100 mg/ml |
1 |
Stikla flakons, 100 ml |
[PDF]
[PDF]
|
| V/SRP/23/0064-03 |
100 mg/ml |
10 |
Stikla flakons, 50 ml |
-
|
| V/SRP/23/0064-04 |
100 mg/ml |
10 |
Stikla flakons, 100 ml |
-
|
|
|
Fypryst
|
2.5 mg/ml
|
V/DCP/12/0063
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP53AX15
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
cutaneous spray, solution
|
| International name (active substance): |
Fipronil
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
KRKA, d.d., Novo mesto, Slovēnija
|
| Date of authorisation/renewal: |
03-Oct-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 290917LI (03-Oct-2017)
|
| Labelling text: |
[PDF] 290917M (03-Oct-2017)
|
| Summary of product characteristics: |
[PDF] 290917ZA (03-Oct-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/12/0063-01 |
2,5 mg/ml |
1 |
Polietilēna pudele, 100 ml |
-
|
| V/DCP/12/0063-02 |
2,5 mg/ml |
1 |
Polietilēna pudele, 250 ml |
-
|
| V/DCP/12/0063-03 |
2,5 mg/ml |
1 |
Polietilēna pudele, 500 ml |
-
|
|
|
Cefenidex 2 mg/ml + 1 mg/ml
|
-
|
V/MRP/24/0055
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QS01CA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/24/0055-01 |
|
1 |
ZBPE pudele, 10 ml |
-
|
|
|
Cefenicol
|
5 mg/ml
|
V/MRP/24/0056
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QS01AA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/24/0056-01 |
|
1 |
ZBPE pudelīte, 10 ml |
-
|
|
|
Carprofelican
|
50 mg/ml
|
V/DCP/13/0022
|
Le Vet Beheer B.V., Nīderlande
|
QM01AE91
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/13/0022-01 |
50 mg/ml |
1 |
Stikla pudele, 20 ml |
[PDF]
[PDF]
|
| V/DCP/13/0022-02 |
50 mg/ml |
5 |
Stikla pudele, 20 ml |
-
|
| V/DCP/13/0022-03 |
50 mg/ml |
10 |
Stikla pudele, 20 ml |
-
|
|
|
DAXTON
|
100 mg/ml
|
V/DCP/24/0057
|
Cenavisa S.L, Spānija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0057-01 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/24/0057-02 |
|
1 |
Stikla flakons, 250 ml |
-
|
|